Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease

被引:93
作者
Li, T
Holmes, C
Sham, PC
Vallada, H
Birkett, J
Kirov, G
Lesch, KP
Powell, J
Lovestone, S
Collier, D
机构
[1] INST PSYCHIAT,DEPT PSYCHOL MED,MED GENET SECT,LONDON SE5 8AF,ENGLAND
[2] INST PSYCHIAT,DEPT NEUROSCI,LONDON SE5 8AF,ENGLAND
[3] INST PSYCHIAT,SECT GENET EPIDEMIOL,DEPT PSYCHOL MED,LONDON SE5 8AF,ENGLAND
[4] INST PSYCHIAT,SECT OLD AGE PSYCHIAT,LONDON SE5 8AF,ENGLAND
[5] INST PSYCHIAT,DEPT NEUROPATHOL,LONDON SE5 8AF,ENGLAND
[6] W CHINA UNIV MED SCI,DEPT PSYCHIAT RES,CHENGDU 610041,SICHUAN,PEOPLES R CHINA
[7] UNIV WURZBURG,DEPT PSYCHIAT,D-97080 WURZBURG,GERMANY
基金
英国惠康基金;
关键词
allelic association; dementia; depression; gene; 5-HTT; late onset Alzheimer's disease; SERT;
D O I
10.1097/00001756-199702100-00021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
WE examined a deletion/insertion promoter polymorphism of the serotonin transporter gene, which confers an similar to 40% reduction in expression of the protein, in 196 subjects with late onset Alzheimer's disease (AD) and 271 controls. The frequency of the 484 bp low activity allele was elevated in the subjects with AD (p = 0.004), and an excess of the low activity genotype (30%) was also found in comparison with the controls (20%) (chi(2) = 7.16; P = 0.03). This association was unrelated to the age of the subjects or controls, or to epsilon 4 alleles of the ApoE gene. The odds ratio for the effect of the homozygous low activity genotype was 1.7 (95% CI 1.08-2.67), with a population attributable risk of 33% (95% CI 5-54%). These findings indicate that the low activity allele of the serotonin transporter is a risk factor for late onset AD.
引用
收藏
页码:683 / 686
页数:4
相关论文
共 29 条
[1]   CORNELL SCALE FOR DEPRESSION IN DEMENTIA [J].
ALEXOPOULOS, GS ;
ABRAMS, RC ;
YOUNG, RC ;
SHAMOIAN, CA .
BIOLOGICAL PSYCHIATRY, 1988, 23 (03) :271-284
[2]  
ANDERSSON A, 1992, GERONTOLOGY, V38, P127
[3]   BIOCHEMICAL ASSESSMENT OF SEROTONERGIC AND CHOLINERGIC DYSFUNCTION AND CEREBRAL ATROPHY IN ALZHEIMERS-DISEASE [J].
BOWEN, DM ;
ALLEN, SJ ;
BENTON, JS ;
GOODHARDT, MJ ;
HAAN, EA ;
PALMER, AM ;
SIMS, NR ;
SMITH, CCT ;
SPILLANE, JA ;
ESIRI, MM ;
NEARY, D ;
SNOWDON, JS ;
WILCOCK, GK ;
DAVISON, AN .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (01) :266-272
[4]   Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: Correlations with depression and neuroleptic medication [J].
Chen, CPLH ;
Alder, JT ;
Bowen, DM ;
Esiri, MM ;
McDonald, B ;
Hope, T ;
Jobst, KA ;
Francis, PT .
JOURNAL OF NEUROCHEMISTRY, 1996, 66 (04) :1592-1598
[5]   The serotonin transporter is a potential susceptibility factor for bipolar affective disorder [J].
Collier, DA ;
Arranz, MJ ;
Sham, P ;
Battersby, S ;
Vallada, H ;
Gill, P ;
Aitchison, KJ ;
Sodhi, M ;
Li, T ;
Roberts, GW ;
Smith, B ;
Morton, J ;
Murray, RM ;
Smith, D ;
Kirov, G .
NEUROREPORT, 1996, 7 (10) :1675-1679
[6]  
Collier DA, 1996, MOL PSYCHIATR, V1, P453
[7]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[8]   CORTICAL PYRAMIDAL NEURON LOSS MAY CAUSE GLUTAMATERGIC HYPOACTIVITY AND COGNITIVE IMPAIRMENT IN ALZHEIMERS-DISEASE - INVESTIGATIVE AND THERAPEUTIC PERSPECTIVES [J].
FRANCIS, PT ;
SIMS, NR ;
PROCTER, AW ;
BOWEN, DM .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) :1589-1604
[9]  
HALLIDAY GM, 1992, ACTA NEUROPATHOL, V84, P638
[10]   AMYLOID DEPOSITION AS THE CENTRAL EVENT IN THE ETIOLOGY OF ALZHEIMERS-DISEASE [J].
HARDY, J ;
ALLSOP, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (10) :383-388